1. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119. [CrossRef] [PubMed]
2. Sarwar, N.; Gao, P.; Kondapally Seshasai, S.R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D.A.; Selvin, E.; Stampfer, M.; et al. Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies. Lancet 2010, 375, 2215–2222. [CrossRef] [PubMed]
3. Carey, I.M.; Critchley, J.A.; Dewilde, S.; Harris, T.; Hosking, F.J.; Cook, D.G. Risk of Infection in Type 1 and Type 2 Diabetes Compared with the General Population: A Matched Cohort Study. Diabetes Care 2018, 41, 513–521. [CrossRef] [PubMed]
4. Hovind, P.; Tarnow, L.; Rossing, P.; Jensen, B.R.; Graae, M.; Torp, I.; Binder, C.; Parving, H.H. Predictors for the Development of Microalbuminuria and Macroalbuminuria in Patients with Type 1 Diabetes: Inception Cohort Study. Br. Med. J. 2004, 328, 1105–1108. [CrossRef]
5. Samsu, N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed. Res. Int. 2021, 2021, 1497449. [CrossRef] [PubMed]
6. Secrist, J.P.; Karnitz, L.; Abraham, R.T. T-Cell Antigen Receptor Ligation Induces Tyrosine Phosphorylation of Phospholipase C-Γ1. J. Biol. Chem. 1991, 266, 12135–12139. [CrossRef]
7. Rhee, S.G.; Bae, Y.S. Regulation of Phosphoinositide-Specific Phospholipase C Isozymes. J. Biol. Chem. 1997, 272, 15045–15048. [CrossRef] [PubMed]
8. Monick, M.M.; Carter, A.B.; Gudmundsson, G.; Mallampalli, R.; Powers, L.S.; Hunninghake, G.W. A Phosphatidylcholine-Specific Phospholipase C Regulates Activation of P42/44 Mitogen-Activated Protein Kinases in Lipopolysaccharide-Stimulated Human Alveolar Macrophages. J. Immunol. 1999, 162, 3005–3012.
9. Carman, G.M.; Han, G.S. Phosphatidic Acid Phosphatase, a Key Enzyme in the Regulation of Lipid Synthesis. J. Biol. Chem. 2009, 284, 2593–2597. [CrossRef]
10. Carman, G.M.; Han, G.-S. Roles of Phosphatidate Phosphatase Enzymes in Lipid Metabolism. Trends Biochem. Sci. 2006, 31, 694–699. [CrossRef]
11. Exton, J.H. Phospholipase D: Enzymology, Mechanisms of Regulation, and Function. Physiol. Rev. 1997, 77, 303–320. [CrossRef] [PubMed]
12. Craven, P.A.; Davidson, C.M.; DeRubertis, F.R. Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose from de Novo Synthesis of Glycerolipids. Diabetes 1990, 39, 667–674. [CrossRef] [PubMed]
13. Thorens, B.; Mueckler, M. Glucose Transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 2010, 298, 141–145. [CrossRef] [PubMed]
14. Jiang, X.; Yang, F.; Brailoiu, E.; Jakubowski, H.; Dun, N.J.; Schafer, A.I.; Yang, X.; Durante, W.; Wang, H. Differential Regulation of Homocysteine Transport in Vascular Endothelial and Smooth Muscle Cells. Diabetes 1993, 42, 80–89. [CrossRef]
15. Nishizuka, Y. Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase, C. Science 1992, 258, 607–614. [CrossRef]
16. Newton, A.C. Regulation of Protein Kinase, C. Curr. Opin. Cell Biol. 1997, 9, 161–167. [CrossRef]
17. Ebinu, J.O.; Bottorff, D.A.; Chan, E.Y.W.; Stang, S.L.; Dunn, R.J.; Stone, J.C. RasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs. Science 1998, 280, 1082–1086. [CrossRef]
18. Lucas, P.; Ukhanov, K.; Leinders-Zufall, T.; Zufall, F. A Diacylglycerol-Gated Cation Channel in Vomeronasal Neuron Dendrites Is Impaired in TRPC2 Mutant Mice: Mechanism of Pheromone Transduction. Neuron 2003, 40, 551–561. [CrossRef]
19. Limatola, C.; Schaap, D.; Moolenaar, W.H.; van Blitterswijk, W.J. Phosphatidic Acid Activation of Protein Kinase C-Zeta Overexpressed in COS Cells: Comparison with Other Protein Kinase C Isotypes and Other Acidic Lipids. Biochem. J. 1994, 304, 1001–1008. [CrossRef]
20. Jones, D.R.; Sanjuan, M.A.; Mérida, I. Type Iα Phosphatidylinositol 4-Phosphate 5-Kinase Is a Putative Target for Increased Intracellular Phosphatidic Acid. FEBS Lett. 2000, 476, 160–165. [CrossRef]
21. Ghosh, S.; Strum, J.C.; Sciorra, V.A.; Daniel, L.; Bell, R.M. Raf-1 Kinase Possesses Distinct Binding Domains for Phosphatidylserine and Phosphatidic Acid: Phosphatidic Acid Regulates the Translocation of Raf-1 in 12-O-Tetradecanoylphorbol-13-Acetate- Stimulated Madin-Darby Canine Kidney Cells. J. Biol. Chem. 1996, 271, 8472–8480. [CrossRef] [PubMed]
22. Fang, Y.; Vilella-Bach, M.; Bachmann, R.; Flanigan, A.; Chen, J. Phosphatidic Acid-Mediated Mitogenic Activation of MTOR Signaling. Science 2001, 294, 1942–1945. [CrossRef] [PubMed]
23. Newton, A.C. Protein Kinase C: Perfectly Balanced. Crit. Rev. Biochem. Mol. Biol. 2018, 53, 208–230. [CrossRef] [PubMed]
24. Parker, P.J.; Coussens, L.; Totty, N.; Rhee, L.; Young, S.; Chen, E.; Stabel, S.; Waterfield, M.D.; Ullrich, A. The Complete Primary Structure of Protein Kinase C—The Major Phorbol Ester Receptor. Science 1986, 233, 853–859. [CrossRef] [PubMed]
25. Knopf, J.L.; Lee, M.H.; Sultzman, L.A.; Kriz, R.W.; Loomis, C.R.; Hewick, R.M.; Bell, R.M. Cloning and Expression of Multiple Protein Kinase C CDNAs. Cell 1986, 46, 491–502. [CrossRef]
26. Ohno, S.; Akita, Y.; Konno, Y.; Imajoh, S.; Suzuki, K. A Novel Phorbol Ester Receptor/Protein Kinase, NPKC, Distantly Related to the Protein Kinase C Family. Cell 1988, 53, 731–741. [CrossRef]
27. Ono, Y.; Fujii, T.; Ogita, K.; Kikkawa, U.; Igarashi, K.; Nishizuka, Y. The Structure, Expression, and Properties of Additional Members of the Protein Kinase C Family. J. Biol. Chem. 1988, 263, 6927–6932. [CrossRef]
28. Nakanishi, H.; Exton, J.H. Purification and Characterization of the ζ Isoform of Protein Kinase C from Bovine Kidney. J. Biol. Chem. 1992, 267, 16347–16354. [CrossRef]
29. Craven, P.A.; DeRubertis, F. Protein Kinase C Is Activated in Glomeruli from Streptozotocin Diabetic Rats. Possible Mediation by Glucose. J. Clin. Investig. 1989, 83, 1667–1675. [CrossRef]
30. Inoguchi, T.; Battan, R.; Handler, E.; Sportsman, J.R.; Heath, W.; King, G.L. Preferential Elevation of Protein Kinase C Isoform Beta II and Diacylglycerol Levels in the Aorta and Heart of Diabetic Rats: Differential Reversibility to Glycemic Control by Islet Cell Transplantation. Proc. Natl. Acad. Sci. USA 1992, 89, 11059–11063. [CrossRef]
31. Ayo, S.H.; Radnik, R.; Garoni, J.A.; Troyer, D.A.; Kreisberg, J.I. High Glucose Increases Diacylglycerol Mass and Activates Protein Kinase C in Mesangial Cell Cultures. Am. J. Physiol. Physiol. 1991, 261, F571–F577. [CrossRef] [PubMed]
32. Koya, D.; King, G.L. Protein Kinase C Activation and the Development of Diabetic Complications. Diabetes 1998, 47, 859–866. [CrossRef] [PubMed]
33. Menne, J.; Park, J.K.; Boehne, M.; Elger, M.; Lindschau, C.; Kirsch, T.; Meier, M.; Gueler, F.; Fiebeler, A.; Bahlmann, F.H.; et al. Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-α-Deficient Diabetic Mice. Diabetes 2004, 53, 2101–2109. [CrossRef] [PubMed]
34. Ohshiro, Y.; Ma, R.C.; Yasuda, Y.; Hiraoka-Yamamoto, J.; Clermont, A.C.; Isshiki, K.; Yagi, K.; Arikawa, E.; Kern, T.S.; King, G.L. Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ-Null Mice. Diabetes 2006, 55, 3112–3120. [CrossRef]
35. Tuttle, K.R.; Bakris, G.L.; Toto, R.D.; McGill, J.B.; Hu, K.; Anderson, P.W. The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes. Diabetes Care 2005, 28, 2686–2690. [CrossRef]
36. Shiba, T.; Inoguchi, T.; Sportsman, J.R.; Heath, W.F.; Bursell, S.; King, G.L. Correlation of Diacylglycerol Level and Protein Kinase C Activity in Rat Retina to Retinal Circulation. Am. J. Physiol. 1993, 265, E783–E793. [CrossRef]
37. Derubertis, F.R.; Craven, P.A. Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy. Diabetes 1994, 43, 1–8. [CrossRef]
38. Babazono, T.; Kapor-Drezgic, J.; Dlugosz, J.A.; Whiteside, C. Altered Expression and Subcellular Localization of Diacylglycerol- Sensitive Protein Kinase C Isoforms in Diabetic Rat Glomerular Cells. Diabetes 1998, 47, 668–676. [CrossRef]
39. Chiarelli, F.; Gaspari, S.; Marcovecchio, M.L. Role of Growth Factors in Diabetic Kidney Disease. Horm. Metab. Res. 2009, 41, 585–593. [CrossRef]
40. Reeves, W.B.; Andreoli, T.E. Transforming Growth Factor β Contributes to Progressive Diabetic Nephropathy. Proc. Natl. Acad. Sci. USA 2000, 97, 7667–7669. [CrossRef]
41. Arora, M.K.; Singh, U.K. Molecular Mechanisms in the Pathogenesis of Diabetic Nephropathy: An Update. Vascul. Pharmacol. 2013, 58, 259–271. [CrossRef] [PubMed]
42. Koya, D.; Jirousek, M.R.; Lin, Y.W.; Ishii, H.; Kuboki, K.; King, G.L. Characterization of Protein Kinase C β Isoform Activation on the Gene Expression of Transforming Growth Factor-β, Extracellular Matrix Components, and Prostanoids in the Glomeruli of Diabetic Rats. J. Clin. Investig. 1997, 100, 115–126. [CrossRef] [PubMed]
43. Hayashida, T.; Schnaper, H.W. High Ambient Glucose Enhances Sensitivity to TGF-B1 via Extracellular Signal-Regulated Kinase and Protein Kinase Cδ Activities in Human Mesangial Cells. J. Am. Soc. Nephrol. 2004, 15, 2032–2041. [CrossRef]
44. Riser, B.L.; Denichilo, M.; Cortes, P.; Baker, C.; Grondin, J.M.; Yee, J.; Narins, R.G. Regulation of Connective Tissue Growth Factor Activity in Cultured Rat Mesangial Cells and Its Expression in Experimental Diabetic Glomerulosclerosis. J. Am. Soc. Nephrol. 2000, 11, 25–38. [CrossRef] [PubMed]
45. Khamaisi, M.; Schrijvers, B.F.; De Vriese, A.S.; Raz, I.; Flyvbjerg, A. The Emerging Role of VEGF in Diabetic Kidney Disease. Nephrol. Dial. Transplant. 2003, 18, 1427–1430. [CrossRef] [PubMed]
46. Hoshi, S.; Tomari, S.; Hoshi, S.; Nomoto, K.I.; Kuromitsu, J.; Nagata, M. High Glucose Induced VEGF Expression via PKC and ERK in Glomerular Podocytes. Biochem. Biophys. Res. Commun. 2002, 290, 177–184. [CrossRef] [PubMed]
47. Xia, L.; Wang, H.; Munk, S.; Frecker, H.; Goldberg, H.J.; Fantus, I.G.; Whiteside, C.I. Reactive Oxygen Species, PKC-A1, and PKC-ζ Mediate High-Glucose-Induced Vascular Endothelial Growth Factor Expression in Mesangial Cells. Am. J. Physiol. Endocrinol. Metab. 2007, 293, 1280–1288. [CrossRef]
48. Thallas-Bonke, V.; Thorpe, S.R.; Coughlan, M.T.; Fukami, K.; Yap, F.Y.T.; Sourris, K.C.; Penfold, S.A.; Bach, L.A.; Cooper, M.E.; Forbes, J.M. Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product-Mediated Damage in Diabetic Nephropathy through a Protein Kinase C-α-Dependent Pathway. Diabetes 2008, 57, 460–469. [CrossRef] [PubMed]
49. Ishii, H.; Jirousek, M.R.; Koya, D.; Takagi, C.; Xia, P.; Clermont, A.; Bursell, S.E.; Kern, T.S.; Ballas, L.M.; Heath, W.F.; et al. Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor. Science 1996, 272, 728–731. [CrossRef]
50. Koya, D.; Haneda, M.; Nakagawa, H.; Isshiki, K.; Sato, H.; Maeda, S.; Sugimoto, T.; Yasuda, H.; Kashiwagi, A.; Ways, D.K.; et al. Amelioration of Accelerated Diabetic Mesangial Expansion by Treatment with a PKC β Inhibitor in Diabetic Db/Db Mice, a Rodent Model for Type 2 Diabetes. FASEB J. 2000, 14, 439–447. [CrossRef]
51. Sheetz, M.J.; Aiello, L.P.; Davis, M.D.; Danis, R.; Bek, T.; Cunha-Vaz, J.; Shahri, N.; Berg, P.H. The Effect of the Oral PKC β Inhibitor Ruboxistaurin on Vision Loss in Two Phase 3 Studies. Investig. Ophthalmol. Vis. Sci. 2013, 54, 1750–1757. [CrossRef] [PubMed]
52. Meier, M.; Park, J.K.; Overheu, D.; Kirsch, T.; Lindschau, C.; Gueler, F.; Leitges, M.; Menne, J.; Haller, H. Deletion of Protein Kinase C-β Isoform in Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model. Diabetes 2007, 56, 346–354. [CrossRef]
53. Kanoh, H.; Yamada, K.; Sakane, F. Diacylglycerol Kinase: A Key Modulator of Signal Transduction? Trends Biochem. Sci. 1990, 15, 47–50. [CrossRef]
54. Sakane, F.; Imai, S.I.; Kai, M.; Yasuda, S.; Kanoh, H. Diacylglycerol Kinases: Why so Many of Them? Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2007, 1771, 793–806. [CrossRef] [PubMed]
55. Topham, M.K.; Prescott, S.M. Mammalian diacylglycerol kinases, a Family of Lipid Kinases with Signaling Functions. J. Biol. Chem. 1999, 274, 11447–11450. [CrossRef]
56. Van Blitterswijk, W.J.; Houssa, B. Properties and Functions of Diacylglycerol Kinases. Cell. Signal. 2000, 12, 595–605. [CrossRef]
57. Kanoh, H.; Yamada, K.; Sakane, F. Diacylglycerol Kinases: Emerging Downstream Regulators in Cell Signaling Systems. J. Biochem. 2002, 131, 629–633. [CrossRef]
58. Sakane, F.; Yamada, K.; Kanoh, H.; Yokoyama, C.; Tanabe, T. Porcine Diacylglycerol Kinase Sequence Has Zinc Finger and E-F Hand Motifs. Nature 1990, 344, 345–348. [CrossRef]
59. Klauck, T.M.; Xu, X.; Mousseau, B.; Jaken, S. Cloning and Characterization of a Glucocorticoid-Induced Diacylglycerol Kinase. J. Biol. Chem. 1996, 271, 19781–19788. [CrossRef]
60. Letwin, K.; Yee, S.P.; Pawson, T. Novel Protein-Tyrosine Kinase CDNAs Related to Fps/Fes and Eph Cloned Using Anti- Phosphotyrosine Antibody. Oncogene 1988, 3, 621–627.
61. Imai, S.; Kai, M.; Yasuda, S.; Kanoh, H.; Sakane, F. Identification and Characterization of a Novel Human Type II Diacylglycerol Kinase, DGK Kappa. J. Biol. Chem. 2005, 280, 39870–39881. [CrossRef]
62. Tang, W.; Bunting, M.; Zimmerman, G.A.; McIntyre, T.M.; Prescott, S.M. Molecular Cloning of a Novel Human Diacylglycerol Kinase Highly Selective for Arachidonate-Containing Substrates. J. Biol. Chem. 1996, 271, 10237–10241. [CrossRef]
63. Bunting, M.; Tang, W.; Zimmerman, G.A.; McIntyre, T.M.; Prescott, S.M. Molecular Cloning and Characterization of a Novel Human Diacylglycerol Kinase Zeta. J. Biol. Chem. 1996, 271, 10230–10236. [CrossRef] [PubMed]
64. Goto, K.; Kondo, H. A 104-KDa Diacylglycerol Kinase Containing Ankyrin-like Repeats Localizes in the Cell Nucleus. Proc. Natl. Acad. Sci. USA 1996, 93, 11196–11201. [CrossRef] [PubMed]
65. Ding, L.; Traer, E.; McIntyre, T.M.; Zimmerman, G.A.; Prescott, S.M. The Cloning and Characterization of a Novel Human Diacylglycerol Kinase, DGKiota. J. Biol. Chem. 1998, 273, 32746–32752. [PubMed]
66. Houssa, B.; Schaap, D.; Van Der Wal, J.; Goto, K.; Kondo, H.; Yamakawa, A.; Shibata, M.; Takenawa, T.; Van Blitterswijk, W.J. Cloning of a Novel Human Diacylglycerol Kinase (DGKθ) Containing Three Cysteine-Rich Domains, a Proline-Rich Region, and a Pleckstrin Homology Domain with an Overlapping Ras-Associating Domain. J. Biol. Chem. 1997, 272, 10422–10428. [CrossRef] [PubMed]
67. Rigotti, A. Absorption, Transport, and Tissue Delivery of Vitamin E. Mol. Asp. Med. 2007, 28, 423–436. [CrossRef]
68. Traber, M.G.; Atkinson, J. Vitamin E, Antioxidant and Nothing More. Free Radic. Biol. Med. 2007, 43, 4–15. [CrossRef] [PubMed]
69. Koya, D.; Lee, I.K.; Ishii, H.; Kanoh, H.; King, G.L. Prevention of Glomerular Dysfunction in Diabetic Rats by Treatment with D-Alpha-Tocopherol. J. Am. Soc. Nephrol. 1997, 8, 426–435.
70. Tada, H.; Ishii, H.; Isogai, S. Protective Effect of D-α-Tocopherol on the Function of Human Mesangial Cells Exposed to High Glucose Concentrations. Metabolism 1997, 46, 779–784. [CrossRef]
71. Kakehi, T.; Yagi, K.; Saito, N.; Shirai, Y. Effects of Vitamin E and Its Derivatives on Diabetic Nephropathy in Rats and Identification of Diacylglycerol Kinase Subtype Involved in the Improvement of Diabetic Nephropathy. Funct. Foods Health Dis. 2017, 7, 816–832. [CrossRef]
72. Shirai, Y.; Segawa, S.; Kuriyama, M.; Goto, K.; Sakai, N.; Naoaki, S. Subtype-Specific Translocation of Diacylglycerol Kinase α and γ and Its Correlation with Protein Kinase C. J. Biol. Chem. 2000, 275, 24760–24766. [CrossRef] [PubMed]
73. Fukunaga-Takenaka, R.; Shirai, Y.; Yagi, K.; Adachi, N.; Sakai, N.; Merino, E.; Merida, I.; Saito, N. Importance of Chroman Ring and Tyrosine Phosphorylation in the Subtype-Specific Translocation and Activation of Diacylglycerol Kinase α by D-α-Tocopherol. Genes Cells 2005, 10, 311–319. [CrossRef] [PubMed]
74. Tasinato, A.; Boscoboinik, D.; Bartoli, G.M.; Maroni, P.; Azzi, A. D-α-Tocopherol Inhibition of Vascular Smooth Muscle Cell Proliferation Occurs at Physiological Concentrations, Correlates with Protein Kinase C Inhibition, and Is Independent of Its Antioxidant Properties. Proc. Natl. Acad. Sci. USA 1995, 92, 12190–12194. [CrossRef]
75. Pryor, W.A.; Cornicelli, J.A.; Devall, L.J.; Tait, B.; Trivedi, B.K.; Witiak, D.T.; Wu, M. A Rapid Screening Test To Determine the Antioxidant Potencies of Natural and Synthetic Antioxidants. J. Org. Chem. 1993, 58, 3521–3532. [CrossRef]
76. Atsumi, H.; Kitada, M.; Kanasaki, K.; Koya, D. Reversal of Redox-Dependent Inhibition of Diacylglycerol Kinase by Antioxidants in Mesangial Cells Exposed to High Glucose. Mol. Med. Rep. 2011, 4, 923–927. [CrossRef]
77. Hayashi, D.; Yagi, K.; Song, C.; Ueda, S.; Yamanoue, M.; Topham, M.; Suzaki, T.; Saito, N.; Emoto, N.; Shirai, Y. Diacylglycerol Kinase Alpha Is Involved in the Vitamin E-Induced Amelioration of Diabetic Nephropathy in Mice. Sci. Rep. 2017, 7, 2597. [CrossRef] [PubMed]
78. Vasavada, N.; Agarwal, R. Role of Oxidative Stress in Diabetic Nephropathy. Adv. Chronic Kidney Dis. 2005, 12, 146–154. [CrossRef]
79. Kaneko, Y.K.; Kobayashi, Y.; Motoki, K.; Nakata, K.; Miyagawa, S.; Yamamoto, M.; Hayashi, D.; Shirai, Y.; Sakane, F.; Ishikawa, T. Depression of Type i Diacylglycerol Kinases in Pancreatic β-Cells from Male Mice Results in Impaired Insulin Secretion. Endocrinology 2013, 154, 4089–4098. [CrossRef] [PubMed]
80. Chibalin, A.V.; Leng, Y.; Vieira, E.; Krook, A.; Björnholm, M.; Long, Y.C.; Kotova, O.; Zhong, Z.; Sakane, F.; Steiler, T.; et al. Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance. Cell 2008, 132, 375–386. [CrossRef]
81. Lonn, E.; Yusuf, S.; Hoogwerf, B.; Pogue, J.; Yi, Q.; Zinman, B.; Bosch, J.; Dagenais, G.; Mann, J.F.E.; Gerstein, H.C. Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes Results of the HOPE Study and micro-hope substudy on behalf of the heart outcomes prevention evaluation (hope) investigators. Diabetes Care 2002, 25, 1919–1927. [CrossRef] [PubMed]
82. Di Vincenzo, A.; Tana, C.; El Hadi, H.; Pagano, C.; Vettor, R.; Rossato, M. Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease. Int. J. Mol. Sci. 2019, 20, 5101. [CrossRef] [PubMed]
83. Tan, S.M.Q.; Chiew, Y.; Ahmad, B.; Kadir, K.A. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial. Nutrients 2018, 10, 1315. [CrossRef]
84. Yokozawa, T.; Nakagawa, T.; Oya, T.; Okubo, T.; Juneja, L.R. Green Tea Polyphenols and Dietary Fibre Protect against Kidney Damage in Rats with Diabetic Nephropathy. J. Pharm. Pharmacol. 2010, 57, 773–780. [CrossRef]
85. Yamabe, N.; Yokozawa, T.; Oya, T.; Kim, M. Therapeutic Potential of (-)-Epigallocatechin 3-O-Gallate on Renal Damage in Diabetic Nephropathy Model Rats. J. Pharmacol. Exp. Ther. 2006, 319, 228–236. [CrossRef] [PubMed]
86. Mohabbulla Mohib, M.; Fazla Rabby, S.M.; Paran, T.Z.; Mehedee Hasan, M.; Ahmed, I.; Hasan, N.; Abu Taher Sagor, M.; Mohiuddin, S. Protective Role of Green Tea on Diabetic Nephropathy—A Review. Cogent. Biol. 2016, 2, 1248166. [CrossRef]
87. Hayashi, D.; Ueda, S.; Yamanoue, M.; Saito, N.; Ashida, H.; Shirai, Y. Epigallocatechin-3-Gallate Activates Diacylglycerol Kinase Alpha via a 67 KDa Laminin Receptor: A Possibility of Galloylated Catechins as Functional Food to Prevent and/or Improve Diabetic Renal Dysfunctions. J. Funct. Foods 2015, 15, 561–569. [CrossRef]
88. Hayashi, D.; Wang, L.; Ueda, S.; Yamanoue, M.; Ashida, H. The Mechanisms of Ameliorating Effect of a Green Tea Polyphenol on Diabetic Nephropathy Based on Diacylglycerol Kinase α. Sci. Rep. 2020, 10, 11790. [CrossRef]
89. Borges, C.M.; Papadimitriou, A.; Duarte, D.A.; Lopes De Faria, J.M.; Lopes De Faria, J.B. The Use of Green Tea Polyphenols for Treating Residual Albuminuria in Diabetic Nephropathy: A Double-Blind Randomised Clinical Trial. Sci. Rep. 2016, 6, 28282. [CrossRef]
90. Ueda, M.; Nishiumi, S.; Nagayasu, H.; Fukuda, I.; Yoshida, K.I.; Ashida, H. Epigallocatechin Gallate Promotes GLUT4 Transloca- tion in Skeletal Muscle. Biochem. Biophys. Res. Commun. 2008, 377, 286–290. [CrossRef]
91. Shahwan, M.; Alhumaydhi, F.; Ashraf, G.M.; Hasan, P.M.Z.; Shamsi, A. Role of Polyphenols in Combating Type 2 Diabetes and Insulin Resistance. Int. J. Biol. Macromol. 2022, 206, 567–579. [CrossRef]
92. Isbrucker, R.A.; Edwards, J.A.; Wolz, E.; Davidovich, A.; Bausch, J. Safety Studies on Epigallocatechin Gallate (EGCG) Preparations. Part 2: Dermal, Acute and Short-Term Toxicity Studies. Food Chem. Toxicol. 2006, 44, 636–650. [CrossRef] [PubMed]
93. Ullmann, U.; Haller, J.; Decourt, J.D.; Girault, J.; Spitzer, V.; Weber, P. Plasma-Kinetic Characteristics of Purified and Isolated Green Tea Catechin Epigallocatechin Gallate (EGCG) after 10 Days Repeated Dosing in Healthy Volunteers. Int. J. Vitam. Nutr. Res. 2004, 74, 269–278. [CrossRef] [PubMed]
94. Hayashi, D.; Ueda, S.; Yamanoue, M.; Ashida, H.; Shirai, Y. Amelioration of Diabetic Nephropathy by Oral Administration of D-α-Tocopherol and Its Mechanisms. Biosci. Biotechnol. Biochem. 2018, 82, 65–73. [CrossRef] [PubMed]
95. Mohan, T.; Velusamy, P.; Chakrapani, L.N.; Srinivasan, A.K.; Singh, A.; Johnson, T.; Periandavan, K. Impact of EGCG Supplemen- tation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis. J. Agric. Food Chem. 2017, 65, 8028–8036. [CrossRef] [PubMed]
96. Mundel, P.; Kriz, W. Structure and Function of Podocytes: An Update. Anat. Embryol. 1995, 192, 385–397. [CrossRef] [PubMed]
97. Mundel, P. Podocyte Biology and Response to Injury. J. Am. Soc. Nephrol. 2004, 13, 3005–3015. [CrossRef]
98. Li, J.J.; Kwak, S.J.; Jung, D.S.; Kim, J.J.; Yoo, T.H.; Ryu, D.R.; Han, S.H.; Choi, H.Y.; Lee, J.E.; Moon, S.J.; et al. Podocyte Biology in Diabetic Nephropathy. Kidney Int. 2007, 72, S36–S42. [CrossRef]
99. Quack, I.; Woznowski, M.; Potthoff, S.A.; Palmer, R.; Königshausen, E.; Sivritas, S.; Schiffer, M.; Stegbauer, J.; Vonend, O.; Rump, L.C.; et al. PKCα Mediates β-Arrestin2-Dependent Nephrin Endocytosis in Hyperglycemia. J. Biol. Chem. 2011, 286, 13959–13970. [CrossRef]
100. Kerjaschki, D.; Ojha, P.P.; Susani, M.; Horvat, R.; Binder, S.; Hovorka, A.; Hillemanns, P.; Pytela, R. A Beta 1-Integrin Receptor for Fibronectin in Human Kidney Glomeruli. Am. J. Pathol. 1989, 134, 481–489.
101. Adler, S. Characterization of Glomerular Epithelial Cell Matrix Receptors. Am. J. Pathol. 1992, 141, 571. [PubMed]
102. Rainero, E.; Caswell, P.T.; Muller, P.A.J.; Grindlay, J.; Mccaffrey, M.W.; Zhang, Q.; Wakelam, M.J.O.; Vousden, K.H.; Graziani, A.; Norman, J.C. Diacylglycerol Kinase α Controls RCP-Dependent Integrin Trafficking to Promote Invasive Migration. J. Cell Biol. 2012, 196, 277–295. [CrossRef]
103. Rainero, E.; Cianflone, C.; Porporato, P.E.; Chianale, F.; Malacarne, V.; Bettio, V.; Ruffo, E.; Ferrara, M.; Benecchia, F.; Capello, D.; et al. The Diacylglycerol Kinase α/Atypical PKC/B1 Integrin Pathway in SDF-1α Mammary Carcinoma Invasiveness. PLoS ONE 2014, 9, 97144. [CrossRef] [PubMed]
104. Dominguez, C.L.; Floyd, D.H.; Xiao, A.; Mullins, G.R.; Benjamin, A.; Xin, W.; Yacur, M.N.; Abounader, R.; Lee, J.K.; Mustata, G.; et al. Therapeutic Target in Glioblastoma and Other Cancers. Cancer Discov. 2013, 3, 782–797. [CrossRef] [PubMed]
105. Yanagisawa, K.; Yasuda, S.; Kai, M.; Imai, S.I.; Yamada, K.; Yamashita, T.; Jimbow, K.; Kanoh, H.; Sakane, F. Diacylglycerol Kinase α Suppresses Tumor Necrosis Factor-α-Induced Apoptosis of Human Melanoma Cells through NF-KB Activation. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2007, 1771, 462–474. [CrossRef]
106. Sakane, F.; Hoshino, F.; Ebina, M.; Sakai, H.; Takahashi, D. The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis. Cancers 2021, 13, 5190. [CrossRef] [PubMed]
107. Yamamoto, T.; Sakai, H.; Sakane, F. EF-Hand Motifs of Diacylglycerol Kinase α Interact Intra-Molecularly with Its C1 Domains. FEBS Open Biol. 2014, 4, 387–392. [CrossRef] [PubMed]
108. Sakane, F.; Yamada, K.; Imai, S.I.; Kanoh, H. Porcine 80-KDa Diacylglycerol Kinase Is a Calcium-Binding and Calcium/Phospholipid- Dependent Enzyme and Undergoes Calcium-Dependent Translocation. J. Biol. Chem. 1991, 266, 7096–7100. [CrossRef]
109. Abe, T.; Lu, X.; Jiang, Y.; Boccone, C.E.; Qian, S.; Vattem, K.M.; Wek, R.C.; Walsh, J.P. Site-Directed Mutagenesis of the Active Site of Diacylglycerol Kinase α: Calcium and Phosphatidylserine Stimulate Enzyme Activity via Distinct Mechanisms. Biochem. J. 2003, 375, 673–680. [CrossRef]
110. Ciprés, A.; Carrasco, S.; Merino, E.; Díaz, E.; Krishna, U.M.; Falck, J.R.; Martínez-A, C.; Mérida, I. Regulation of Diacylglycerol Kinase α by Phosphoinositide 3-Kinase Lipid Products. J. Biol. Chem. 2003, 278, 35629–35635. [CrossRef]
111. Keiko, Y.; Fumio, S. The Different Effects of Sphingosine on Diacylglycerol Kinase Isozymes in Jurkat Cells, a Human T-Cell Line. Biochim. Biophys. Acta Lipids Lipid Metab. 1993, 1169, 211–216. [CrossRef]
112. Keiko, Y.; Fumio, S.; Shin-ichi, I.; Haruo, T. Sphingosine Activates Cellular Diacylglycerol Kinase in Intact Jurkat Cells, a Human T-Cell Line. Biochim. Biophys. Acta Lipids Lipid Metab. 1993, 1169, 217–224. [CrossRef]
113. Liu, K.; Kunii, N.; Sakuma, M.; Yamaki, A.; Mizuno, S.; Sato, M.; Sakai, H.; Kado, S.; Kumagai, K.; Kojima, H.; et al. A Novel Diacylglycerol Kinase α-Selective Inhibitor, CU-3, Induces Cancer Cell Apoptosis and Enhances Immune Response. J. Lipid Res. 2016, 57, 368–379. [CrossRef]
114. Hayashi, D.; Tsumagari, R.; Liu, K.; Ueda, S.; Yamanoue, M.; Sakane, F.; Shirai, Y. Screening of Subtype-Specific Activators and Inhibitors for Diacylglycerol Kinase. J. Biochem. 2019, 165, 517–522. [CrossRef]
115. Takahashi, D.; Suzuki, K.; Sakamoto, T.; Iwamoto, T.; Murata, T.; Sakane, F. Crystal Structure and Calcium-Induced Conformational Changes of Diacylglycerol Kinase α EF-Hand Domains. Protein Sci. 2019, 28, 694–706. [CrossRef] [PubMed]
116. Jumper, J.; Evans, R.; Pritzel, A.; Green, T.; Figurnov, M.; Ronneberger, O.; Tunyasuvunakool, K.; Bates, R.; Žídek, A.; Potapenko, A.; et al. Highly Accurate Protein Structure Prediction with AlphaFold. Nature 2021, 596, 583–589. [CrossRef] [PubMed]
117. Varadi, M.; Anyango, S.; Deshpande, M.; Nair, S.; Natassia, C.; Yordanova, G.; Yuan, D.; Stroe, O.; Wood, G.; Laydon, A.; et al. AlphaFold Protein Structure Database: Massively Expanding the Structural Coverage of Protein-Sequence Space with High-Accuracy Models. Nucleic Acids Res. 2022, 50, D439–D444. [CrossRef]
118. Aulakh, S.S.; Bozelli, J.C.; Epand, R.M. Exploring the AlphaFold Predicted Conformational Properties of Human Diacylglycerol Kinases. J. Phys. Chem. B 2022, 126, 7172–7183. [CrossRef] [PubMed]
119. Merino, E.; Sanjuán, M.A.; Moraga, I.; Ciprés, A.; Mérida, I. Role of the Diacylglycerol Kinase α-Conserved Domains in Membrane Targeting in Intact T Cells. J. Biol. Chem. 2007, 282, 35396–35404. [CrossRef]
120. Matsubara, T.; Ikeda, M.; Kiso, Y.; Sakuma, M.; Yoshino, K.I.; Sakane, F.; Merida, I.; Saito, N.; Shirai, Y. C-Abl Tyrosine Kinase Regulates Serum-Induced Nuclear Export of Diacylglycerol Kinase α by Phosphorylation at Tyr-218. J. Biol. Chem. 2012, 287, 5507–5517. [CrossRef]
121. Azzi, A.; Stocker, A. Vitamin E: Non-Antioxidant Roles. Prog. Lipid Res. 2000, 39, 231–255. [CrossRef]
122. Rao, N.C.; Barsky, S.H.; Terranova, V.P.; Liotta, L.A. Isolation of a Tumor Cell Laminin Receptor. Biochem. Biophys. Res. Commun. 1983, 111, 804–808. [CrossRef]
123. Malinoff, H.L.; Wicha, M.S. Isolation of a Cell Surface Receptor Protein for Laminin from Murine Fibrosarcoma Cells. J. Cell Biol. 1983, 96, 1475–1479. [CrossRef]
124. Lesot, H.; Kühl, U.; von der Mark, K.; Mark, K. Isolation of a Laminin-Binding Protein from Muscle Cell Membranes. EMBO J. 2018, 2, 861–865. [CrossRef]
125. Gauczynski, S.; Peyrin, J.; Haõ, Â.; Leucht, C.; Hundt, C.; Rieger, R.; Krasemann, S.; Deslys, J.; Dormont, D.; Weiss, S.; et al. The 37-KDa/67-KDa Laminin Receptor Acts as the Cell-Surface Receptor for the Cellular Prion Protein. EMBO J. 2001, 20, 5863–5875. [CrossRef]
126. Wang, K.S.; Kuhn, R.J.; Strauss, E.G.; Ou, S.; Strauss, J.H. High-Affinity Laminin Receptor Is a Receptor for Sindbis Virus in Mammalian Cells. J. Virol. 1992, 66, 4992–5001. [CrossRef]
127. Tachibana, H.; Koga, K.; Fujimura, Y.; Yamada, K. A Receptor for Green Tea Polyphenol EGCG. Nat. Struct. Mol. Biol. 2004, 11, 380–381. [CrossRef]
128. Umeda, D.; Yano, S.; Yamada, K.; Tachibana, H. Green Tea Polyphenol Epigallocatechin-3-Gallate Signaling Pathway through 67-KDa Laminin Receptor. J. Biol. Chem. 2008, 283, 3050–3058. [CrossRef]
129. Kumazoe, M.; Sugihara, K.; Tsukamoto, S.; Huang, Y.; Tsurudome, Y.; Suzuki, T.; Suemasu, Y.; Ueda, N.; Yamashita, S.; Kim, Y.; et al. 67-KDa Laminin Receptor Increases CGMP to Induce Cancer-Selective Apoptosis. J. Clin. Investig. 2013, 123, 787–799. [CrossRef] [PubMed]
130. Hong Byun, E.; Fujimura, Y.; Yamada, K.; Tachibana, H. TLR4 Signaling Inhibitory Pathway Induced by Green Tea Polyphenol Epigallocatechin-3-Gallate through 67-KDa Laminin Receptor. J. Immunol. 2010, 185, 33–45. [CrossRef] [PubMed]
131. Tsukamoto, S.; Huang, Y.; Umeda, D.; Yamada, S.; Yamashita, S.; Kumazoe, M.; Kim, Y.; Murata, M.; Yamada, K.; Tachibana, H. 67-KDa Laminin Receptor-Dependent Protein Phosphatase 2A (PP2A) Activation Elicits Melanoma-Specific Antitumor Activity Overcoming Drug Resistance. J. Biol. Chem. 2014, 289, 32671–32681. [CrossRef] [PubMed]
132. Kumazoe, M.; Kadomatsu, M.; Bae, J.; Otsuka, Y.; Fujimura, Y. Src Mediates Epigallocatechin-3-O-Gallate-Elicited Acid Sphin- gomyelinase Activation. Molecules 2020, 25, 5481. [CrossRef] [PubMed]
133. Hayashi, D.; Mouchlis, V.D.; Okamoto, S.; Namba, T.; Wang, L.; Li, S.; Ueda, S.; Yamanoue, M.; Tachibana, H.; Arai, H.; et al. Vitamin E Functions by Association with a Novel Binding Site on the 67 KDa Laminin Receptor Activating Diacylglycerol Kinase. J. Nutr. Biochem. 2022, 110, 109129. [CrossRef] [PubMed]
134. Bhat, K.P.L.; Aldape, K. Not Expecting the Unexpected: Diacylglycerol Kinase Alpha as a Cancer Target. Cancer Discov. 2013, 3, 726–727. [CrossRef]
135. Krishna, S.; Zhong, X.P. Regulation of Lipid Signaling by Diacylglycerol Kinases during T Cell Development and Function. Front. Immunol. 2013, 4, 178. [CrossRef]
136. Velnati, S.; Ruffo, E.; Massarotti, A.; Talmon, M.; Varma, K.S.S.; Gesu, A.; Fresu, L.G.; Snow, A.L.; Bertoni, A.; Capello, D.; et al. Identification of a Novel DGKα Inhibitor for XLP-1 Therapy by Virtual Screening. Eur. J. Med. Chem. 2019, 164, 378–390. [CrossRef]
論文の公開元へ
